Lin Qiuyuan, Zhang Jin, Liu Liling, Kong Jilie, Fang Xueen
Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China.
Qingdao International Travel Healthcare Center, Qingdao Customs, Qingdao 266071, P. R. China.
ACS Omega. 2022 Oct 21;7(43):38409-38416. doi: 10.1021/acsomega.2c03499. eCollection 2022 Nov 1.
In this work, we report a fast, portable, and economical microfluidic platform for the simultaneous detection of nucleic acid and proteins. Using SARS-CoV-2 as a target, this microfluidic chip enabled to simultaneously detect the SARS-CoV-2 RNA (N gene) antigen (or specific IgG antibody) with respective detection limits of 1 copy/μL for nucleic acid, 0.85 ng/mL for antigen, and 5.80 ng/mL for IgG within 30 min with high stability and anti-interference ability. The capability of this system in clinical applications was further evaluated using clinical samples, displaying 100% sensitivity and 100% specificity for COVID-19 diagnosis. These findings demonstrate the potential of this method to be used for the detection and subsequent control of pathogens.
在本研究中,我们报道了一种用于同时检测核酸和蛋白质的快速、便携式且经济的微流控平台。以严重急性呼吸综合征冠状病毒2(SARS-CoV-2)作为检测目标,该微流控芯片能够在30分钟内同时检测SARS-CoV-2核糖核酸(N基因)、抗原(或特异性IgG抗体),核酸的检测限为1拷贝/微升,抗原的检测限为0.85纳克/毫升,IgG的检测限为5.80纳克/毫升,具有高稳定性和抗干扰能力。使用临床样本进一步评估了该系统在临床应用中的能力,对2019冠状病毒病(COVID-19)诊断显示出100%的灵敏度和100%的特异性。这些发现证明了该方法在病原体检测及后续控制方面的应用潜力。